Tag: drug discovery
Drugmaker turns to ChatGPT and Gemini to revive renin inhibitors
Sheo Pharmaceuticals used the chatbots to study past failures, then built its own models to design a candidate.
Flagship’s ProFound nets $35M to hunt preeclampsia targets
Flagship's ProFound Therapeutics gets up to $35M from the Gates Foundation to hunt new preeclampsia drug targets.
KAIST’s K-Fold model predicts drug-protein binding 25x faster
KAIST's homegrown K-Fold model predicts protein-drug binding structures up to 25 times faster than existing AI.
Nine repurposed drugs show neuron protection in Sanfilippo model
A Nature Communications study pairs drug screening with machine learning against MPS IIIA.
GenBio launches stateful AIDO Cell to simulate whole human cells
GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and proteins shape whole-cell behavior.
Kyowa Kirin picks Benchling and Cognizant to modernize drug R&D
Kyowa Kirin adopts Benchling's AI R&D platform with Cognizant handling the rollout at two research parks.
Mayo Clinic AI finds drug path to ‘undruggable’ cancer protein
AI screening of nearly 40,000 compounds produced a GIPC1 inhibitor that slowed pancreatic tumor growth in preclinical models.
AWS becomes Novo Nordisk’s preferred AI partner for drug discovery
Novo Nordisk names AWS its preferred cloud and AI partner, opening a London hub to speed drug discovery.